Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Insulet (PODD)

Insulet appoints Jonathan Mazelsky, former IDEXX CEO, to its board effective July 1, 2026

Neutral Impact 2 of 5 leadership Written later

Insulet Corporation's board appointed Jonathan J. Mazelsky as a Class II director effective July 1, 2026, and he will stand for stockholder election at the 2027 annual meeting. The filing describes him as an independent director with prior experience as IDEXX Laboratories' president and CEO and no reported related-party transactions, and it does not include financial results or guidance.

Key points

  • Appointment made June 24, 2026, effective July 1, 2026; announced in a press release dated June 25, 2026
  • Mazelsky was President and CEO of IDEXX Laboratories from October 2019 to May 2026 and is now its Executive Chair
  • Initial director grant of restricted stock units with a grant date fair value of $216,548, pro-rated from a $260,000 annual award

The filing

CompanyInsulet (PODD)
Form8-K, current report
Filed with the SECJun 25, 2026, 7:06 AM ET
Accession number0001145197-26-000148

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:56 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 25, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.